Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis

Background and Aim. Liver cirrhosis is often accompanied by insidious cardiac dysfunction. This retrospective cross-sectional study is aimed at exploring the correlation between serum cardiac markers and decompensating events in liver cirrhosis. Methods. Cirrhotic patients who were consecutively hos...

Full description

Bibliographic Details
Main Authors:	Miaomiao Li, Zeqi Guo, Dan Zhang, Xiangbo Xu, Fernando Gomes Romeiro, Andrea Mancuso, Jingqiao Zhang, Ruirui Feng, Xinmiao Zhou, Cen Hong, Xingshun Qi
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2020/4019289

Similar Items

Acute Brucellosis and Cirrhosis: The Triggering Event of Fatal Liver Decompensation
by: Maria Kosmidou, et al.
Published: (2020-01-01)

Prognostic Assessment and Management of Liver Cirrhosis
by: Xingshun Qi, et al.
Published: (2017-01-01)

Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
by: Vikrant Rachakonda, et al.
Published: (2016-01-01)

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
by: Soon Kyu Lee, et al.
Published: (2018-12-01)

Serum potassium levels and prognosis in HBV-associated decompensated cirrhosis
by: Cai, M., et al.
Published: (2021)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
by: Deepak N. Amarapurkar
Published: (2011-01-01)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
by: Richard Guan, et al.
Published: (2011-01-01)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
by: Gemma Llibre-Nieto, et al.
Published: (2021-04-01)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
by: Pooja D. Amarapurkar, et al.
Published: (2011-01-01)

Effects of alprostadil combined with nucleoside antiviral drugs on liver function, liver fibrosis markers and serum inflammatory factors in patients with decompensated liver cirrhosis with HBV infection
by: Jing-Chun Song, et al.
Published: (2019-04-01)

COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01)

Improving Survival in Decompensated Cirrhosis
by: Amar Nath Mukerji, et al.
Published: (2012-01-01)

Management options in decompensated cirrhosis
by: Shah NL, et al.
Published: (2015-07-01)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
by: JianPing Wu, et al.
Published: (2019-01-01)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.
by: Georgios Grammatikos, et al.
Published: (2015-01-01)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
by: Manasa Kandula, et al.
Published: (2016-12-01)

Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
by: Antonio Riva, et al.
Published: (2020-12-01)

Improving Survival in Patients with Decompensated Cirrhosis
by: Deepak Amarapurkar, et al.
Published: (2011-01-01)

Diagnostic value of serum cystatin C and urotensin II for hepatorenal syndrome in patients with decompensated liver cirrhosis
by: ZHENG Xiaoli
Published: (2013-08-01)

Some practical issues in the management of patients with decompensated liver cirrhosis
by: E A Fedosina, et al.
Published: (2019-08-01)

Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis
by: Ted Spiewak, et al.
Published: (2020-07-01)

Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis
by: Ashraf Abd El-Khalik Barakat, et al.
Published: (2015-10-01)

Multiple infarcted regenerative nodules in liver cirrhosis after decompensation of cirrhosis: a case series
by: Müllhaupt Beat, et al.
Published: (2010-11-01)

Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
by: Daniela Matei, et al.
Published: (2021-08-01)

An excerpt of update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
by: ZHANG Jingqiao, et al.
Published: (2018-04-01)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
by: Jeffrey Nadelson, et al.
Published: (2016-01-01)

Splanchnic and Systemic Haemodynamic Derangement in Decompensated Cirrhosis
by: Søren Møller, et al.
Published: (2001-01-01)

Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis
by: ZHANG Huikai, et al.
Published: (2016-06-01)

Association of hyponatremia with degree of liver injury and complications in patients with decompensated liver cirrhosis
by: WU Jian, et al.
Published: (2017-02-01)

Relationship of hyponatremia with degree of liver injury and prognosis in patients with decompensated liver cirrhosis
by: LI Ying, et al.
Published: (2016-03-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis
by: Shingo Usui, et al.
Published: (2017-10-01)

Control of patients′ condition and prevention of complications in patients with decompensated liver cirrhosis
by: ZHONG Sheng, et al.
Published: (2016-06-01)

The correlation of serum zinc concentration with liver cirrhosis events
by: Farzad Jassemi Zergani, et al.
Published: (2017-09-01)

Application of antibacterial agents in patients with liver cirrhosis
by: HAN Dan, et al.
Published: (2017-03-01)

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis
by: Le Wang, et al.
Published: (2021-04-01)

Impact of Bacterial Translocation on Sarcopenia in Patients with Decompensated Cirrhosis
by: Cynthia Tsien, et al.
Published: (2019-10-01)

Correction of renal dysfunction in patients with the decompensated course of cirrhosis
by: A. S. Tugushev, et al.
Published: (2014-06-01)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
by: F. N. U. Shailesh, et al.
Published: (2014-01-01)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
by: Camila Alvarez-Silva, et al.
Published: (2019-02-01)